Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort, Thromb Res, vol.158, pp.157-60, 2017. ,
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study, Lancet Oncol, vol.15, issue.1, pp.35-47, 2014. ,
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration, J Clin Oncol, vol.33, issue.27, pp.2938-2986, 2015. ,
Thrombosis in children with acute lymphoblastic leukemia ,
, Thromb Res, vol.111, issue.3, pp.125-156, 2003.
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients, Blood, vol.108, issue.7, pp.2216-2238, 2006. ,
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01, Blood, vol.97, issue.5, pp.1211-1219, 2001. ,
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia, Leuk Lymphoma, vol.57, issue.4, pp.748-57, 2016. ,
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer, vol.64, p.26694, 2017. ,
Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer, Pediatr Blood Cancer, vol.51, issue.6, pp.792-799, 2008. ,
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer, vol.97, pp.508-524, 2003. ,
Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study, Blood, vol.115, issue.24, pp.4999-5004, 2010. ,
Thrombosis and acute lymphoblastic leukaemia, Br J Haematol ,
,
, Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study. BMC Cancer, vol.17, 2017.
,
, Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration, Blood, vol.101, issue.7, pp.2529-2562, 2003.
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment, 16. Levy-Mendelovich S, vol.126, issue.2, pp.94-101, 2010. ,
,
, Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis, Res Pract Thromb Haemost, vol.3, issue.2, pp.234-275, 2019.
,
, Venous Thrombosis in Children with Acute Lymphoblastic Leukemia Treated on DCOG ALL-9 and ALL-10 Protocols: The Effect of Fresh Frozen Plasma. TH Open, pp.109-125, 2019.
,
, Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood, vol.131, pp.2475-84, 2018.
,
, THROMBOTECT -a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents, Haematologica, 2019.
,
An openlabel randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial, Thromb Res, vol.109, issue.2-3, pp.101-109, 2003. ,
,
TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial, BMC Pediatr, vol.17, issue.1, 2017. ,
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design, Thromb Haemost, 2019. ,
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer, J Thromb Haemost, vol.10, issue.5, pp.807-821, 2012. ,
Innefficacity of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy ,
,
, Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation, Thromb Haemost, vol.109, issue.4, pp.633-675, 2013.
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving lasparaginase for acute lymphoblastic leukemia: Results of the PARKAA study, Thromb Haemost, vol.90, issue.08, pp.235-279, 2003. ,
,
, Changes in antithrombin and fibrinogen levels during induction chemotherapy with Lasparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study
, Haematologica, vol.93, issue.10, pp.1488-94, 2008.
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome, Brain, vol.128, issue.3, pp.477-89, 2005. ,
Thrombosis and acute lymphoblastic leukaemia, Br J Haematol ,
Traitement anticoagulant des thromboses veineuses cérébrales de l'enfant et du nouveau-né. Les recommandations de la Société française de neurologie pédiatrique (SFNP). Arch Pédiatrie, vol.18, pp.446-58, 2011. ,
Antithrombotic Therapy in Neonates and Children, Chest, vol.141, issue.2, pp.737-801, 2012. ,
Asparaginase-related venous thrombosis in UKALL 2003-re-exposure to asparaginase is feasible and safe, Br J Haematol, vol.149, issue.3, pp.410-413, 2010. ,
, VII. ANNEXES Annexe, vol.1